BMRN logo

BioMarin Pharmaceutical (BMRN)

Profile

Full Name

BioMarin Pharmaceutical Inc.

Ticker Symbol

BMRN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 26, 1999

Indexes

Not included

Website

http://www.biomarin.com

Employees

3040

Key Details

Price

$59.27(+0.77%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.85B(+17.97% YoY)

Annual EPS

$2.21(+154.02% YoY)

PE ratio

26.94

Next earnings date

Apr 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$59.27
BMRN price is $59.27

30-Day Relative Volume

0.55
BMRN 30-day relative volume is 0.55

Price Performance

Price Today change

+0.77%
BMRN price is up +0.77% today

Price YTD change

-9.83%
BMRN price is down -9.83% since January 1st

Price 1-year change

-34.49%
BMRN price is down -34.49% year-on-year

Price 3-year change

-28.55%
BMRN price is down -28.55% over the past 3 years

Price Range

Price All-time high

$151.75
BMRN price is currently -60.94% below its historical high of $151.75

Price 3-year low

$52.93
BMRN price is currently +11.98% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.31B
BMRN market capitalization is $11.31 billion

Market cap 3-year change

-26.28%
BMRN market capitalization is down -26.28% over the past 3 years

Market cap All-time high

$24.01B
BMRN market capitalization is currently -52.91% below its historical high of $24.01 billion

Market cap sector rank

93.59%
BMRN market capitalization is higher than 93.59% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.53%
BMRN shares outstanding is up +0.53% year-on-year

Shares Outstanding 3-Year Change

+3.18%
BMRN shares outstanding is up +3.18% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.70
BMRN beta is 0.70

200-day SMA

$72.02
BMRN price is currently -17.70% below its 200-day simple moving average

50-day SMA

$67.16
BMRN price is currently -11.75% below its 50-day simple moving average

RSI

36.57
BMRN 14-day relative strength index is 36.57

Volume

0.55
BMRN 30-day relative volume is 0.55

ATR

$2.89
BMRN average true range is $2.89

10-day Historical Volatility

80.07%
BMRN 10-day historical volatility is 80.07%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.85B
BMRN annual revenue is $2.85 billion

Revenue Analysts estimate

$3.14B
BMRN annual revenue is currently -9.15% lower than the consensus analysts' forecast

Revenue 1-year change

+17.97%
BMRN annual revenue is up +17.97% year-on-year

Revenue Sector rank

88.02%
BMRN annual revenue is higher than 88.02% of companies in Healthcare sector

EPS

EPS

$2.21
BMRN annual earnings per share is $2.21

EPS Analysts estimate

$4.30
BMRN annual earnings per share is currently -48.64% lower than the consensus analysts' forecast

EPS 1-year change

+154.02%
BMRN annual earnings per share is up +154.02% year-on-year

EPS Sector rank

92.64%
BMRN annual earnings per share is higher than 92.64% of companies in Healthcare sector

Profit

Gross profit

$2.27B
BMRN annual gross profit is $2.27 billion

Gross margin

79.67%
BMRN annual gross profit margin is 79.67%

Operating profit

$474.21M
BMRN annual operating income is $474.21 million

Operating margin

16.62%
BMRN annual operating profit margin is 16.62%

Net income

$426.86M
BMRN annual net profit is $426.86 million

Net margin

14.96%
BMRN annual net profit margin is 14.96%

Expenses

Total expenses

$2.38B
BMRN annual total expenses is $2.38 billion

Operating expenses

$1.80B
BMRN annual total operating expenses is $1.80 billion

Cost of goods sold

$580.24M
BMRN annual cost of goods sold is $580.24 million

Selling, general & administrative expenses

$1.01B
BMRN annual SGA is $1.01 billion

Depreciation and amortization

$96.43M
BMRN annual depreciation & amortization is $96.43 million

Interest expense

$12.34M
BMRN annual interest expense is $12.34 million

Income tax

$114.90M
BMRN annual income tax is $114.90 million

EBIT & EBITDA

EBIT

$554.43M
BMRN annual earnings before interest & taxes is $554.43 million

EBITDA

$650.86M
BMRN annual EBITDA is $650.86 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$6.99B
BMRN annual total assets is $6.99 billion

Non current assets

$3.76B
BMRN annual long term assets is $3.76 billion

Current assets

$3.23B
BMRN annual total current assets is $3.23 billion

Cash and cash equivalents

$942.84M
BMRN annual cash & cash equivalents is $942.84 million

Accounts receivable

$660.53M
BMRN annual accounts receivable is $660.53 million

Inventory

$1.23B
BMRN annual inventory is $1.23 billion

Liabilities

Total liabilities

$1.33B
BMRN annual total liabilities is $1.33 billion

Long term liabilities

$723.96M
BMRN annual total long term liabilities is $723.96 million

Current liabilities

$606.99M
BMRN annual total current liabilities is $606.99 million

Accounts payable

$235.40M
BMRN annual accounts payable is $235.40 million

Debt

Total debt

$602.71M
BMRN annual total debt is $602.71 million

Total debt 1-year change

-45%
BMRN annual total debt is down -45% year-on-year

Long term debt

$595.14M
BMRN annual long term debt is $595.14 million

Short term debt

$7.57M
BMRN annual short term debt is $7.57 million

Equity & Capital

Shareholders equity

$5.66B
BMRN annual stockholders equity is $5.66 billion

Book value

$5.66B
BMRN annual book value is $5.66 billion

Retained earnings

-$194.69M
BMRN annual retained earnings is -$194.69 million

Working capital

$2.63B
BMRN annual working capital is $2.63 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$572.84M
BMRN annual cash flow from operations is $572.84 million

Cash from operations 1-year change

+259.69%
BMRN annual cash flow from operations is up +259.69% year-on-year

Cash from investing

$136.49M
BMRN annual cash flow from investing activities is $136.49 million

Cash from investing 1-year change

+222.7%
BMRN annual cash flow from investing activities is up +222.7% year-on-year

Cash from financing

-$526.45M
BMRN annual cash flow from financing activities is -$526.45 million

Cash from financing 1-year change

-2711.17%
BMRN annual cash flow from financing activities is down -2711.17% year-on-year

CAPEX

CAPEX

$97.42M
BMRN annual capital expenditures is $97.42 million

CAPEX 1-year change

-9.47%
BMRN annual capital expenditures is down -9.47% year-on-year

Free Cash Flow

Free cash flow

$475.42M
BMRN annual free cash flow is $475.42 million

Free cash flow 1-year change

+820.51%
BMRN annual free cash flow is up +820.51% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

79.67%
BMRN annual gross profit margin is 79.67%

Operating margin

16.62%
BMRN annual operating profit margin is 16.62%

Net margin

14.96%
BMRN annual net profit margin is 14.96%

ROA & ROE

ROA

6.17%
BMRN annual return on assets is 6.17%

ROE

8.05%
BMRN annual return on equity is 8.05%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

26.94
BMRN price to earnings ratio is 26.94

PE ratio Sector rank

57.35%
BMRN price to earnings ratio is higher than 57.35% of companies in Healthcare sector

PB Ratio

PB ratio

2.00
BMRN price to book ratio is 2.00

PB ratio Sector rank

62.27%
BMRN price to book ratio is higher than 62.27% of companies in Healthcare sector

PS Ratio

PS ratio

3.96
BMRN price to sales ratio is 3.96

PS ratio Sector rank

60.64%
BMRN price to sales ratio is higher than 60.64% of companies in Healthcare sector

Enterprise value

Enterprise value

$10.97B
BMRN enterprise value is $10.97 billion

Enterprise value Sector rank

92.73%
BMRN enterprise value is higher than 92.73% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

16.85
BMRN EV/EBITDA is 16.85

EV/EBITDA Sector rank

89.83%
BMRN EV/EBITDA is higher than 89.83% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.33
BMRN annual current ratio is 5.33

Quick ratio

3.29
BMRN annual quick ratio is 3.29

Leverage

Debt to equity

0.11
BMRN annual debt to equity ratio is 0.11

Interest coverage ratio

44.93
BMRN annual interest coverage ratio is 44.93

Risk & Stability

Piotroski F-Score

7
BMRN piotroski f-score is 7

Altman Z-Score

6.18
BMRN altman z-score is 6.18

Analyst ratings

Recent major analysts updates

Feb 24, 25 Oppenheimer
Outperform
Feb 20, 25 UBS
Buy
Feb 20, 25 Scotiabank
Sector Perform
Feb 20, 25 RBC Capital
Sector Perform
Feb 20, 25 Piper Sandler
Overweight
Feb 20, 25 Citigroup
Neutral
Feb 20, 25 Cantor Fitzgerald
Overweight
Feb 20, 25 B of A Securities
Buy
Dec 12, 24 Cantor Fitzgerald
Overweight
Nov 15, 24 Wolfe Research
Outperform

Institutional Ownership

Similar stocks

SNN logo
Smith & Nephew (SNN)
RDY logo
Dr Reddys Laboratories Limited (RDY)
RVTY logo
Revvity (RVTY)
INCY logo
Incyte (INCY)
UHS logo
Universal Health Services (UHS)
DVA logo
DaVita (DVA)
SOLV logo
Solventum (SOLV)
THC logo
Tenet Healthcare (THC)
ICLR logo
ICON Public Limited (ICLR)
  • What is the ticker symbol for BioMarin Pharmaceutical?
  • Does BioMarin Pharmaceutical pay dividends?
  • What sector is BioMarin Pharmaceutical in?
  • What industry is BioMarin Pharmaceutical in?
  • What country is BioMarin Pharmaceutical based in?
  • When did BioMarin Pharmaceutical go public?
  • Is BioMarin Pharmaceutical in the S&P 500?
  • Is BioMarin Pharmaceutical in the NASDAQ 100?
  • Is BioMarin Pharmaceutical in the Dow Jones?
  • When was BioMarin Pharmaceutical's last earnings report?
  • When does BioMarin Pharmaceutical report earnings?
  • Should I buy BioMarin Pharmaceutical stock now?

What is the ticker symbol for BioMarin Pharmaceutical?

The ticker symbol for BioMarin Pharmaceutical is NASDAQ:BMRN

Does BioMarin Pharmaceutical pay dividends?

No, BioMarin Pharmaceutical does not pay dividends

What sector is BioMarin Pharmaceutical in?

BioMarin Pharmaceutical is in the Healthcare sector

What industry is BioMarin Pharmaceutical in?

BioMarin Pharmaceutical is in the Biotechnology industry

What country is BioMarin Pharmaceutical based in?

BioMarin Pharmaceutical is headquartered in United States

When did BioMarin Pharmaceutical go public?

BioMarin Pharmaceutical's initial public offering (IPO) was on July 26, 1999

Is BioMarin Pharmaceutical in the S&P 500?

No, BioMarin Pharmaceutical is not included in the S&P 500 index

Is BioMarin Pharmaceutical in the NASDAQ 100?

No, BioMarin Pharmaceutical is not included in the NASDAQ 100 index

Is BioMarin Pharmaceutical in the Dow Jones?

No, BioMarin Pharmaceutical is not included in the Dow Jones index

When was BioMarin Pharmaceutical's last earnings report?

BioMarin Pharmaceutical's most recent earnings report was on Feb 19, 2025

When does BioMarin Pharmaceutical report earnings?

The next expected earnings date for BioMarin Pharmaceutical is Apr 24, 2025

Should I buy BioMarin Pharmaceutical stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page